As has been previously reported, elevated KLK6 expression can accelerate the EMT in colon cancer cells and can activate the signal transduction pathways controlling cell invasion and metastasis via the Transforming Growth Factor β2 (TGF-β2) signaling pathway [28,29]. Here, TGFB2 is linked to malignant colon neoplasm.